Body temperature monitoring is a vital sign in evaluating a person's general health and preventing and managing diseases linked with abnormal temperature variations. The body temperature is usually maintained within a narrow range through thermoregulation. Body temperature monitors track temperature changes and assist healthcare professionals in detecting potential health issues related to fever, such as infections, inflammatory diseases and various other medical conditions. The body temperature monitors market offerings include oral armpit thermometers, tympanic thermometers, forehead/temporal artery thermometers and continuous temperature monitoring devices. The need for an accurate, easy-to-use and fast body temperature monitoring solution is driving the demand for advanced digital thermometers across healthcare settings.

The Global Body Temperature Monitoring Market is estimated to be valued at US$ 1.5 Bn in 2024 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the body temperature monitoring market are Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd. Regent Pacific Group Limited offers a wide range of professional medical devices including thermometers, pulse oximeters, nebulizers etc. Menarini Group provides thermometers, blood pressure monitors, glucose meters and other medical equipment.

The body temperature monitoring market offers significant growth opportunities, mainly driven by rising demand for remote and self-monitoring solutions due to the COVID-19 pandemic. Self-monitoring devices allow mass screening and prevent infection spread. There is also a growing need for continuous temperature monitoring solutions for patients in the intensive care units, emergency rooms and operating rooms.

The major players in the body temperature monitoring market are focused on global expansion through partnerships and mergers acquisitions. For instance, in 2022, Dong-A Pharmaceutical Co., Ltd. acquired Aytu BioScience to strengthen its product portfolio and commercial footprint in the U.S. market. Ampio Pharmaceuticals, Inc. has collaborations with various global institutions to conduct clinical trials for COVID-19 therapy and other inflammatory conditions requiring temperature monitoring.

Market Drivers

The growing prevalence of fever-causing illnesses worldwide is a major driver for the body temperature monitoring market. According to the World Health Organization (WHO), fever is one of the most common presenting symptoms of disease, affecting over 1 billion people every year. Rising incidences of infectious diseases such as malaria, pneumonia, influenza, Covid-19 etc. have increased demand for thermometers and advanced temperature monitoring solutions in healthcare facilities.

Market Restraints

Accuracy concerns related to oral and forehead thermometers limit their adoption, especially in clinical settings. Factors like user-error and environmental impacts can affect the reliability of temperature readings from select monitors. Additionally, lengthy time consumption of conventional thermometers, potential for cross-contamination and invasive procedures associated with some devices restrain market potential to some extent.

Segment Analysis

The body temperature monitoring market is dominated by oral and rectal temperature measurement sub segment as it provides accurate and instant temperature reading. Oral and rectal temperature measurement devices are conventional products which have been used widely from decades. The sub segment held over 40% market share in 2024 owing to its reliability and accurate results.

Tympanic temperature measurement sub segment captured second largest share and is expected to witness strong growth during forecast period. Tympanic devices measure ear temperature which registers core body temperature faster than oral route. They provide temperature reading within seconds and is often preferred for pediatric monitoring. Increasing demand for non-invasive monitoring devices will propel growth of tympanic sub segment between 2023 to 2030.

Global Analysis

North America accounted for around 35% market share in global body temperature monitoring market in 2024. Presence of major players, high healthcare spending, rising prevalence of fever cases and infectious diseases will augment demand for body temperature monitoring devices in the region.

Asia Pacific is projected to be the fastest growing regional market during forecast period. Factors such as growing geriatric population, rising incidence of chronic diseases and improving healthcare infrastructure will boost demand. China and India are likely to offer significant opportunities for manufacturers due to large customer base and increased investment in healthcare sector.